| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000011868 |
| Receipt No. | R000013577 |
| Official scientific title of the study | New product for oral food challenge test in children ;the development and the utility |
| Date of disclosure of the study information | 2013/09/26 |
| Last modified on | 2018/05/17 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | New product for oral food challenge test in children ;the development and the utility | |
| Title of the study (Brief title) | New product for oral food challenge test in children ;the development and the utility | |
| Region |
|
|
| Condition | ||
| Condition | egg allergy,milk allergy,wheat allergy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose is to certify that the test using new product is equal the induced rate, the extent of causing an allergy symptom to the usual test and that the test using new product is more utility than the usual test. |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | To investigate is that their age,sex,another allergic disease,antigen-specific IgE antibody titer are not difference in the test using new product grop and the usual test group.
To certify that the test using new product is equal the induced rate, the extent of causing an allergy symptom to the usual test. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | The patient is that need to complete remove their target food.
High induction rate group,that is the induced rate is over 0.6(it's expected from probability curve in Japanese Pediatric Guideline for Food Allergy 2012). The test is an usual test. |
|
| Interventions/Control_2 | The patient is that need to complete remove their target food.
High induction rate group,that is the induced rate is over 0.6(it's expected from probability curve in Japanese Pediatric Guideline for Food Allergy 2012). The test is an using new product. |
|
| Interventions/Control_3 | The patient is that need to complete remove their target food.
Low induction rate group,that is the induced rate is under 0.6(it's expected from probability curve in Japanese Pediatric Guideline for Food Allergy 2012). The test is an usual test. |
|
| Interventions/Control_4 | The patient is that need to complete remove their target food.
Low induction rate group,that is the induced rate is under 0.6(it's expected from probability curve in Japanese Pediatric Guideline for Food Allergy 2012). The test is an using new product. |
|
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | There is indication of oral food challenge test(Refer to Japanese pediatiric guidline for oral challenge test in Food allergy 2009) and to obtain there consent from the attorney of the child. | |||
| Key exclusion criteria | 1.The condition of being unstoppable anti-allergy drug,theophylline preparation,steroid drugs.
2.The charge of research judge in an improper the test. |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Natsuki Yoshioka |
| Organization | St.Marianna university school of medicine |
| Division name | pediatrics |
| Address | 2-16-1,Sugao miyamae-ku,Kawaski-city,Kanagawa-ken |
| TEL | 044-977-8111 |
| natsuki-desu@marianna-u.ac.jp | |
| Public contact | |
| Name of contact person | Natsuki yoshioka |
| Organization | St.Marianna university school of medicine |
| Division name | pediatrics |
| Address | 2-16-1,Sugao miyamae-ku,Kawaski-city,Kanagawa-ken |
| TEL | 044-977-8111 |
| Homepage URL | |
| k-sienbu.mail@marianna-u.ac.jp | |
| Sponsor | |
| Institute | St.Marianna university school of medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Science and technology agency |
| Organization | |
| Division | |
| Category of Funding Organization | Government offices of other countries |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | AJINOMOTO |
| Name of secondary funder(s) | iwamotoseika,A-LIFE |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 聖マリアンナ医科大学病院(神奈川県)、川崎市立多摩病院(神奈川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013577 |